Drug intelligence / Profile preview

z-val-ala-asp fluoromethyl ketone

Development stage
Unknown
Modality
Peptides, Small Molecules
01

Overview

Z-Val-Ala-Asp fluoromethyl ketone (commonly abbreviated as Z-VAD-FMK) is a synthetic small molecule that acts as a non-methylated, competitive, and irreversible inhibitor of caspase 1 (also known as interleukin 1 beta-converting enzyme or ICE), as well as other caspases. It is widely used in research to inhibit apoptosis by blocking the activity of caspases, which are key mediators of programmed cell death. Unlike some related compounds, it does not require an esterase for activation and can be used directly with purified enzymes. It is considered a pan-caspase inhibitor due to its broad activity against multiple caspase family members. Its primary use is experimental and investigational; it has not been approved for clinical use in humans[2][3][4][5][9].

Brand names
C2105C-2105C 2105
Other names
N-[(Benzyloxy)carbonyl]-L-valyl-N-[(2S)-1-carboxy-4-fluoro-3-oxo-2-butanyl]-L-alaninamidebenzyloxycarbonyl-Val-Ala-DL-Asp-fluoromethylketoneCbz-Val-Ala-DL-Asp-CH2FCbz-Val-Ala-DL-Asp-CH-2FCbz-Val-Ala-DL-Asp-CH 2F
02

Targets

CASP1 (Caspase-1)CASP4 (Caspase-4)CASP3 (Caspase-3)

Beyond the preview

Go deeper on z-val-ala-asp fluoromethyl ketone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on z-val-ala-asp fluoromethyl ketone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call